Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Osteoporosis in Men With Prostate Cancer
NCT00048841Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alendronate in osteoporosis, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started May 2002; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00048841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048841.